Original Article

You have full text access to this OnlineOpen article

Psychologic intervention improves survival for breast cancer patients

A randomized clinical trial

  1. Barbara L. Andersen PhD1,2,†,*,
  2. Hae-Chung Yang PhD1,
  3. William B. Farrar MD2,3,
  4. Deanna M. Golden-Kreutz PhD4,
  5. Charles F. Emery PhD1,
  6. Lisa M. Thornton PhD1,
  7. Donn C. Young PhD2,
  8. William E. Carson III MD2,3

Article first published online: 17 NOV 2008

DOI: 10.1002/cncr.23969

Issue

Cancer

Cancer

Volume 113, Issue 12, pages 3450–3458, 15 December 2008

Additional Information

How to Cite

Andersen, B. L., Yang, H.-C., Farrar, W. B., Golden-Kreutz, D. M., Emery, C. F., Thornton, L. M., Young, D. C. and Carson, W. E. (2008), Psychologic intervention improves survival for breast cancer patients. Cancer, 113: 3450–3458. doi: 10.1002/cncr.23969

Author Information

  1. 1

    Department of Psychology, Ohio State University, Columbus, Ohio

  2. 2

    Comprehensive Cancer Center and Solove Research Institute, Ohio State University, Columbus, Ohio

  3. 3

    Department of Surgery, College of Medicine, Ohio State University, Columbus, Ohio

  4. 4

    Department of Internal Medicine, College of Medicine, Ohio State University, Columbus, Ohio

  1. †

    Fax: (614) 688-8261

*Department of Psychology, 1835 Neil Avenue, Ohio State University, Columbus, OH 43210-1222

Publication History

  1. Issue published online: 4 DEC 2008
  2. Article first published online: 17 NOV 2008
  3. Manuscript Accepted: 22 JUL 2008
  4. Manuscript Revised: 18 JUL 2008
  5. Manuscript Received: 15 MAY 2008

Funded by

  • National Institute of Mental Health. Grant Number: RO1MH51487
  • National Cancer Institute. Grant Numbers: R01CA92704, K05 CA098133, KA24 CA93670, P01 CA95426
  • American Cancer Society. Grant Number: PBR-89
  • LongabergerCompany-American Cancer Society. Grant Number: PBR-89A
  • US Army Medical Research Acquisition Activity. Grant Numbers: DAMD17-94-J-4165, DAMD17-96-1-6294, DAMD17-97-1-7062
  • Ohio State University Comprehensive Cancer Center. Grant Number: P30 CA16058
  • Walther Cancer Institute

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (174K)

REFERENCES

  • 1
    Chida Y,Hamer M,Wardle J,Steptoe A. Do stress-related psychological factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008; 5: 466‒475.
  • 2
    Dhabhar FS,McEwen BS. Bi-directional effects of stress on immune function: Possible explanations for salubrious as well as harmful effects. In: AderR, ed. Psychoneuroimmunology. New York, NY: Elsevier; 2007: 723‒760.
  • 3
    Antoni MH,Lutgendorf SK,Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006; 6: 240‒248.
  • 4
    Miller AH,Ancoli-Israel S,Bower JE,Capuron L,Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008; 26: 971‒982.
  • 5
    Andersen BL,Kiecolt-Glaser JK,Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol. 1994; 49: 389‒404.
  • 6
    Andersen BL,Farrar WB,Golden-Kreutz DM, et al. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol. 2004; 22: 3570‒3580.
  • 7
    FlemingID,CooperJS,MurphyGP,SullivanBO,SobinLH,YarbroJW, eds. AJCC Cancer Staging Manual.5th ed. Philadelphia: Lippincott-Raven; 1997.
  • 8
    White SJ,Freedman LS. Allocation of patients to treatment group in a controlled clinical trial. Br J Cancer. 1978; 37: 849‒857.
  • 9
    Scott NW,McPherson GC,Ramsay CR,Campbell MK. The method of minimization for allocation to clinical trials: a review. Control Clin Trials. 2002; 23: 662‒674.
  • 10
    Andersen BL,Farrar WB,Golden-Kreutz D, et al. Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun. 2007; 21: 953‒961.
  • 11
    Andersen BL,Shelby RA,Golden-Kreutz DM. Results from an RCT of a psychological intervention for patients with cancer: I. Mechanisms of change. J Consult Clin Psychol. 2007; 75: 927‒938.
  • 12
    Horowitz M,Wilner N,Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979; 41: 209‒218.
  • 13
    Kohout FJ,Berkman LF,Evans DA,Cornoni-Huntley J. Two shorter forms of the CES-D Depression Symptoms Index. J Aging Health. 1993; 5: 179‒193.
  • 14
    Cox DR. Regression models and life-tables. J R Stat Soc. 1972; 34: 187‒220.
  • 15
    Karnofsky DA,Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacleodCM, ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1949: 199‒205.
  • 16
    McNair DM,Lorr M,Droppleman LF. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
  • 17
    Confer PD. The James Cancer Registry. Columbus, OH: The Ohio State University Comprehensive Cancer Center; 2008.
  • 18
    Schairer C,Mink PJ,Carroll L,Devesa SS. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst. 2004; 96: 1311‒1321.
  • 19
    Kissane DW,Bloch S,Smith GC, et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology. 2003; 12: 532‒546.
    Direct Link:
  • 20
    Kissane DW,Grabsch B,Clarke DM, et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology. 2007; 16: 277.
    Direct Link:
  • 21
    Goodwin PJ,Leszcz M,Ennis M. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345: 1719‒1726.
  • 22
    Spiegel D,Butler LD,Giese-Davis J, et al. Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer. 2007; 110: 1130‒1138.
    Direct Link:
  • 23
    Vandewalle B,Revillion F,Lefebvre J. Functional beta-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol. 1990; 116: 303‒306.
  • 24
    Sood AK,Bhatty R,Kamat AA, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res. 2006; 12: 369‒375.
  • 25
    Stefanski V,Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol Behav. 1996; 60: 277‒282.
  • 26
    Masur K,Niggemann B,Zanker KS,Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001; 61: 2866‒2869.
  • 27
    Rangarajan S,Enserink JM,Kuiperij H, et al. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the I22-adrenergic receptor. J Cell Biol. 2003; 160: 487‒493.
  • 28
    Thaker PH,Lutgendorf SK,Sood AK. The neuroendocrine impact of chronic stress on cancer. Cell Cycle. 2007; 6: 430‒433.
  • 29
    Raison CL,Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychol. 2003; 54: 283‒294.
  • 30
    Badino GR,Novelli A,Girardi C,Di Carlo F. Evidence for functional β-adrenoceptor subtypes in CG-5 breast cancer cells. Pharmacol Res. 1996; 33: 255‒260.
  • 31
    Kronfol Z,Nair M,Zhang Q,Hil EE,Brown MB. Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosom Med. 1997; 59: 42‒50.
  • 32
    Rich T,Innominato PF,Boerner J, et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 2005; 11: 1757‒1764.
  • 33
    Sephton SE,Sapolsky RM,Kraemer HC,Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000; 92: 994‒1000.
  • 34
    Mormont MC,Waterhouse J,Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 2000; 6: 3038‒3045.
  • 35
    Ben-Eliyahu S,Yirmiya R,Liebeskind JC,Taylor AN,Gale RP. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun. 1991; 5: 193‒205.
  • 36
    Kalinichenko VV,Mokyr MB,Graf LHJr,Cohen RL,Chambers DA. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J Immunol. 1999; 163: 2492‒2499.
  • 37
    Andersen BL,Farrar WB,Golden-Kreutz D, et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 1998; 90: 30‒36.
  • 38
    Kim S,Keku TO,Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 2008; 68: 323‒328.
  • 39
    Elenkov IJ,Chrousos GP. Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann N Y Acad Sci. 2002; 966: 290‒303.
    Direct Link:
  • 40
    Merritt WM,Lin YG,Spannuth WA, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst. 2008; 100: 359‒372.
  • 41
    Thaker PH,Han LY,Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006; 12: 939‒944.
  • 42
    Bunt SK,Sinha P,Clements VK,Leips J,Ostrand-Rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007; 67: 10019‒10026.
  • 43
    Wu W,Chaudhuri S,Brickley DR,Pang D,Karrison T,Conzen SD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res. 2004; 64: 1757‒1764.
  • 44
    Thornton LM,Andersen BL,Carson WEIII. Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother. 2008; 57: 1471‒1481.
  • 45
    Morrow GR,Andrews PL,Hickok JT,Roscoe JA,Matteson S. Fatigue associated with cancer and its treatment. Support Care Cancer. 2002; 10: 389‒398.
  • 46
    Anisman H,Hayley S,Turrin N,Merali Z. Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol. 2002; 5: 357‒373.
  • 47
    Ruka W,Rutkowski P,Kaminska J,Rysinska A,Steffen J. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Ann Oncol. 2001; 12: 1423‒1432.
  • 48
    Redd WH,Montgomery GH,DuHamel KN. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst. 2001; 93: 810‒823.
  • 49
    Sheard T,Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of 2 meta-analyses. Br J Cancer. 1999; 80: 1770‒1780.
  • 50
    Adler NE,Page AEK. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: The National Academies Press; 2008.
  • 51
    Beslija SEA,Bonneterre J,Burstein HJ, et al. For the Central European Cooperative Group. Consensus on the medical treatment of metastatic breast cancer. Breast Cancer Res Treat. 2003; 81: 1‒7.
  • 52
    HewittM,HerdmanR,HollandJ, eds. The effectiveness of psychosocial interventions for women with breast cancer. In: Meeting Psychosocial Needs of Women with Breast Cancer. Washington, DC: The National Academies Press; 2004: 95–132.
View Full Article (HTML) Get PDF (174K)